GEA Pharma Systems has signed an agreement with a U.S. pharmaceutical company to supply a complete continuous processing line for the production of solid dose drugs. The order is for ConsiGma oral solid dosage continuous processing equipment and represents the first phase of a potentially long-term commitment for this customer, according to GEA. Delivery is scheduled for early 2013. The order is to deliver a continuous solid dosage production platform, including continuous blending, wet granula...